Evidence map›Paper›PMID 27565317›Full record

ArticleChemosphere2016

High-throughput exposure modeling to support prioritization of chemicals in personal care products.

Susan A Csiszar, Alexi S Ernstoff, Peter Fantke, David E Meyer, Olivier Jolliet

Abstract read
In one paragraph

Article in Chemosphere, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Exposure forecasting - ExpoCast - for data-poor chemicals in commerce and the environment.Journal of exposure science & environmental epidemiology · 2022
    Review
  5. Review
  6. Article
  7. High Throughput Risk and Impact Screening of Chemicals in Consumer Products.Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Article
  8. Building a European exposure science strategy.Journal of exposure science & environmental epidemiology · 2020
    Review
  9. Qualitative approach to comparative exposure in alternatives assessment.Integrated environmental assessment and management · 2019
    Article
  10. New Approach Methodologies for Exposure Science.Current opinion in toxicology · 2019
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Susan A CsiszarOak Ridge Institute for Science and Education (ORISE) Research Participation Program, hosted at U.S. Environmental Protection Agency, Cincinnati, OH, 45268, USA. Electronic address: susan.csiszar@gmail.com.
Alexi S ErnstoffQuantitative Sustainability Assessment Division, Department of Management Engineering, Technical University of Denmark, Kgs. Lyngby, Denmark.
Peter FantkeQuantitative Sustainability Assessment Division, Department of Management Engineering, Technical University of Denmark, Kgs. Lyngby, Denmark.
David E MeyerOffice of Research and Development, National Risk Management Research Laboratory, U.S. Environmental Protection Agency, Cincinnati, OH 45268, USA.
Olivier JollietEnvironmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: ojolliet@umich.edu.

Funding

Intramural EPA EPA999999NIEHS NIH HHS 27302C0115
6 · The paper itself

Abstract

We demonstrate the application of a high-throughput modeling framework to estimate exposure to chemicals used in personal care products (PCPs). As a basis for estimating exposure, we use the product intake fraction (PiF), defined as the mass of chemical taken by an individual or population per mass of a given chemical used in a product. We calculated use- and disposal- stage PiFs for 518 chemicals for five PCP archetypes. Across all product archetypes the use- and disposal- stage PiFs ranged from 10(-5) to 1 and 0 to 10(-3), respectively. There is a distinction between the use-stage PiF for leave-on and wash-off products which had median PiFs of 0.5 and 0.02 across the 518 chemicals, respectively. The PiF is a function of product characteristics and physico-chemical properties and is maximized when skin permeability is high and volatility is low such that there is no competition between skin and air losses from the applied product. PCP chemical contents (i.e. concentrations) were available for 325 chemicals and were combined with PCP usage characteristics and PiF yielding intakes summed across a demonstrative set of products ranging from 10(-8)-30 mg/kg/d, with a median of 0.1 mg/kg/d. The highest intakes were associated with body lotion. Bioactive doses derived from high-throughput in vitro toxicity data were combined with the estimated PiFs to demonstrate an approach to estimate bioactive equivalent chemical content and to screen chemicals for risk.

Indexed as

CosmeticsEcologyEnvironmental ExposureEnvironmental MonitoringHumansModels, StatisticalParabensPermeabilityPhthalic AcidsRisk AssessmentSkinToxicity TestsCosmeticsParabensphthalic acidPhthalic AcidsExposure modelingHigh-throughputMass balance modelingPersonal care productsProduct intake fractionRisk screening

Identifiers

PMID27565317
PMCPMC7359637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.